[HTML][HTML] History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder
C Heidbreder, PJ Fudala, MK Greenwald - Drug and alcohol dependence …, 2023 - Elsevier
Buprenorphine-based medications were first approved by the United States Food and Drug
Administration in 2002 for the treatment of opioid dependence, or opioid use disorder (OUD) …
Administration in 2002 for the treatment of opioid dependence, or opioid use disorder (OUD) …
The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era
ABSTRACT Background Background: In response to the COVID-19 pandemic, the US
Substance Abuse and Mental Health Services Administration (SAMHSA) allowed for an …
Substance Abuse and Mental Health Services Administration (SAMHSA) allowed for an …
Telemedicine-delivered treatment for substance use disorder: A scoping review
Introduction The COVID pandemic prompted a significant increase in the utilization of
telemedicine (TM) for substance use disorder (SUD) treatment. As we transition towards a …
telemedicine (TM) for substance use disorder (SUD) treatment. As we transition towards a …
Assessment of community-level vulnerability and access to medications for opioid use disorder
Importance Given that COVID-19 and recent natural disasters exacerbated the shortage of
medication for opioid use disorder (MOUD) services and were associated with increased …
medication for opioid use disorder (MOUD) services and were associated with increased …
Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior
Drug overdose is the leading cause of accidental death in the US with deaths from opioid
overdose occurring at a higher rate in rural areas. The gaps in the provision of healthcare …
overdose occurring at a higher rate in rural areas. The gaps in the provision of healthcare …
Types and sources of stigma on opioid use treatment and recovery communities on reddit
Background: Digitally-mediated peer support may improve opioid use disorder (OUD)
recovery. Our objective was to examine the types and sources of stigma that people seek …
recovery. Our objective was to examine the types and sources of stigma that people seek …
Opioid use and COVID-19: a secondary analysis of the impact of relaxation of methadone take-home dosing guidelines on use of illicit opioids
V Panwala, E Thorn, S Amiri, ME Socias… - The American Journal …, 2023 - Taylor & Francis
Background: An exemption to existing US regulation of methadone maintenance therapy
after the onset of the COVID− 19 pandemic permitted increased take-home doses beginning …
after the onset of the COVID− 19 pandemic permitted increased take-home doses beginning …
Disparities in access to opioid treatment programs and buprenorphine providers by race and ethnicity in the contiguous US
Background The burden of drug overdose mortality varies by race and ethnicity, with
American Indian/Alaska Native (AI/AN), Black, and White people experiencing the largest …
American Indian/Alaska Native (AI/AN), Black, and White people experiencing the largest …
Changes in buprenorphine and methadone supplies in the US during the COVID-19 pandemic
Importance The opioid crisis has been exacerbated by the COVID-19 pandemic in the US,
with concerns over major disruptions to medication treatment of opioid use disorder …
with concerns over major disruptions to medication treatment of opioid use disorder …
Racial and ethnic disparities in emergency department–initiated buprenorphine across five health care systems
WC Holland, F Li, B Nath, MM Jeffery… - Academic …, 2023 - Wiley Online Library
Background Opioid overdose deaths have disproportionately impacted Black and Hispanic
populations, in part due to disparities in treatment access. Emergency departments (EDs) …
populations, in part due to disparities in treatment access. Emergency departments (EDs) …